Introducing evidence surveillance as a research stream

I've taken a little while to get this post done because I've been waiting for my recently-published article to go from online-first to being citeable with volume and page numbers. Last year, I was asked to write an editorial on the topic of industry influence on clinical evidence for the Journal of Epidemiology & Community Health, … Continue reading Introducing evidence surveillance as a research stream

‘Implosion’ for the old model of drug discovery

Traditional drug-discovery model ripe for reform : Nature News In this recent discussion of the significant problems facing drug discovery, Daniel Cressey suggests that one of the biggest problems with private enterprise doing drug discovery is that they regularly chase the same targets in parallel and do not know that others have already discarded them after … Continue reading ‘Implosion’ for the old model of drug discovery